EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma

Annette T Hastie iD, Andrew C Bishop, Mohammad S Khan, Eugene R Bleecker, Mario Castro, Loren C Denlinger, Serpil C Erzurum, John V Fahy, Elliot Israel, Bruce D Levy, David T Mauger, Deborah A Meyers und 5 weitere

Clinical & Experimental Allergy · 2024

DOI: 10.1111/cea.14447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2024. Verfasst von Annette T Hastie und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Asthma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, AstraZeneca, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Previous bronchoalveolar lavage fluid (BALF) proteomic analysis has evaluated limited numbers of subjects for only a few proteins of interest, which may differ between asthma and normal controls. Our objective was to examine a more comprehensive inflammatory biomarker panel in quantitative proteomic analysis for a large asthma cohort to identify molecular phenotypes distinguishing severe from nonsevere asthma.

Methods

Bronchoalveolar lavage fluid from 48 severe and 77 nonsevere adult asthma subjects were assessed for 75 inflammatory proteins, normalized to BALF total protein concentration. Validation of BALF differences was sought through equivalent protein analysis of autologous sputum. Subjects' data, stratified by asthma severity, were analysed by standard statistical tests, principal component analysis and 5 machine learning algorithms.

Results

The severe group had lower lung function and greater health care utilization. Significantly increased BALF proteins for severe asthma compared to nonsevere asthma were fibroblast growth factor 2 (FGF2), TGFα, IL1Ra, IL2, IL4, CCL8, CCL13 and CXCL7 and significantly decreased were platelet‐derived growth factor a‐a dimer (PDGFaa), vascular endothelial growth factor (VEGF), interleukin 5 (IL5), CCL17, CCL22, CXCL9 and CXCL10. Four protein differences were replicated in sputum. FGF2, PDGFaa and CXCL7 were independently identified by 5 machine learning algorithms as the most important variables for discriminating severe and nonsevere asthma. Increased and decreased proteins identified for the severe cluster showed significant protein–protein interactions for chemokine and cytokine signalling, growth factor activity, and eosinophil and neutrophil chemotaxis differing between subjects with severe and nonsevere asthma.

Conclusion

These inflammatory protein results confirm altered airway remodelling and cytokine/chemokine activity recruiting leukocytes into the airways of severe compared to nonsevere asthma as important processes even in stable status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AAsthmaAdultHumansProteomicsFibroblast Growth Factor 2CytokinesBronchoalveolar LavageChemokinesBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

bronchoalveolar lavage fluidchemokinescytokinesgrowth factorsmachine learningsevere asthma

Substanzen

Vascular Endothelial Growth Factor AFibroblast Growth Factor 2CytokinesChemokines

Autor:innen und Institutionen

  • Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA.
  • Department of Pulmonary, Critical Care and Sleep Medicine, Kansas University Medical Center, Kansas City, Kansas, USA.
  • Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pulmonary and Critical Care Medicine, University of California-San Francisco, San Francisco, California, USA.

ORCID-Profile: Annette T Hastie

Förderung

  • NHLBI NIH HHS
  • AstraZeneca
  • National Heart, Lung, and Blood Institute
  • Genentech
  • Boehringer Ingelheim
  • MedImmune
  • GlaxoSmithKline
  • Regeneron Pharmaceuticals

Zitieren

APA

Hastie, A. T., Bishop, A. C., Khan, M. S., Bleecker, E. R., Castro, M., Denlinger, L. C., Erzurum, S. C., Fahy, J. V., Israel, E., Levy, B. D., Mauger, D. T., Meyers, D. A., Moore, W. C., Ortega, V. E., Peters, S. P., Wenzel, S. E., & Steele, C. H. (2024). Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14447

Vancouver

Hastie AT, Bishop AC, Khan MS, Bleecker ER, Castro M, Denlinger LC, et al. Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma. Clinical & Experimental Allergy. 2024. doi:10.1111/cea.14447

BibTeX
@article{Hastie2024,
  author = {Hastie, Annette T and Bishop, Andrew C and Khan, Mohammad S and Bleecker, Eugene R and Castro, Mario and Denlinger, Loren C and Erzurum, Serpil C and Fahy, John V and Israel, Elliot and Levy, Bruce D and Mauger, David T and Meyers, Deborah A and Moore, Wendy C and Ortega, Victor E and Peters, Stephen P and Wenzel, Sally E and Steele, Chad H},
  title = {Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma},
  journal = {Clinical & Experimental Allergy},
  year = {2024},
  doi = {10.1111/cea.14447}
}
Kostenlos starten →